Orthotopic model of lung cancer: isolation of bone micro-metastases after tumor escape from Osimertinib treatment - Université de Rennes Accéder directement au contenu
Article Dans Une Revue BMC Cancer Année : 2021

Orthotopic model of lung cancer: isolation of bone micro-metastases after tumor escape from Osimertinib treatment

Résumé

Background: Osimertinib is a third generation tyrosine kinase inhibitor (TKI) that targets the epidermal growth factor receptor (EGFR) in lung cancer. However, although this molecule is not subject to some of the resistance mechanisms observed in response to first generation TKIs, ultimately, patients relapse because of unknown resistance mechanisms. New relevant non-small cell lung cancer (NSCLC) mice models are therefore required to allow the analysis of these resistance mechanisms and to evaluate the efficacy of new therapeutic strategies. Methods: Briefly, PC-9 cells, previously modified for luciferase expression, were injected into the tail vein of mice. Tumor implantation and longitudinal growth, almost exclusively localized in the lung, were evaluated by bioluminescence. Once established, the tumor was treated with osimertinib until tumor escape and development of bone metastases. Results: Micro-metastases were detected by bioluminescence and collected for further analysis. Conclusion: We describe an orthotopic model of NSCLC protocol that led to lung primary tumor nesting and, after osimertinib treatment, by metastases dissemination, and that allow the isolation of these small osimertinib-resistant micro-metastases. This model provides new biological tools to study tumor progression from the establishment of a lung tumor to the generation of drug-resistant micro-metastases, mimicking the natural course of the disease in human NSCLC patients.
Fichier principal
Vignette du fichier
Jarry2021_Article_OrthotopicModelOfLungCancerIso.pdf (1.5 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

inserm-03228487 , version 1 (18-05-2021)

Identifiants

Citer

Ulrich Jarry, Mégane Bostoën, Raphaël Pineau, Laura Chaillot, Valentine Mennessier, et al.. Orthotopic model of lung cancer: isolation of bone micro-metastases after tumor escape from Osimertinib treatment. BMC Cancer, 2021, 21 (1), pp.530. ⟨10.1186/s12885-021-08205-9⟩. ⟨inserm-03228487⟩
31 Consultations
71 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More